Related Experiment Video

Updated: Aug 16, 2026

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model
09:00

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model

Published on: April 17, 2026

The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-beta signalling

Stephen J Wicks1, Katherine Haros, Marjorie Maillard

  • 1School of Biological Sciences, University of East Anglia, Earlham Road, Norwich Norfolk NR4 7TJ, UK.

Oncogene
|July 20, 2005
PubMed

Insights

Ubiquitin C-terminal hydrolase UCH37 interacts with Smad7 and deubiquitinates the TGF-beta receptor, upregulating TGF-beta signaling. This identifies UCH37 as a potential therapeutic target in cancer.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Biology

Background:

  • Transforming growth factor-beta (TGF-beta) signaling is crucial in cancer, regulated by Smad proteins and their ubiquitination.
  • Smurf proteins mediate proteasomal degradation of Smads and receptors, acting as key regulators.
  • Deubiquitinating enzymes (DUBs) can reverse ubiquitination, but their role in TGF-beta signaling is largely unexplored.

Purpose of the Study:

  • To investigate the interaction between Smads and the deubiquitinating enzyme UCH37.
  • To determine UCH37's effect on TGF-beta receptor stability and signaling.
  • To explore UCH37 as a potential therapeutic target in cancer.

Main Methods:

  • GST pull-down assays to assess protein interactions.
  • Co-immunoprecipitation to confirm endogenous and transfected protein complex formation.
  • RNA interference (RNAi) to knockdown UCH37 expression.
  • Reporter assays to measure TGF-beta-dependent transcriptional activity.

Main Results:

  • UCH37 binds strongly to Smad7 and weakly to Smad2/3.
  • UCH37 deubiquitinates and stabilizes the type I TGF-beta receptor.
  • Overexpression of UCH37 enhances TGF-beta-dependent transcription.
  • Knockdown of UCH37 reverses the upregulation of TGF-beta signaling.

Conclusions:

  • UCH37 plays a novel role in regulating TGF-beta signaling by deubiquitinating the TGF-beta receptor.
  • UCH37's interaction with Smad7 is distinct from Smurf binding sites.
  • UCH37 represents a potential therapeutic target for modulating TGF-beta signaling in cancer.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates09:47

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates

Published on: May 10, 2022

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...